Achillion Competitors

Summary

Achillion Pharmaceuticals competes with Harmony Gold, Vindicator Silver, Summit Materials, Shake Shack, and Zijin Mining; as well as few others. The company conducts business under Communication Services sector and is part of Advertising Agencies industry. Analyzing Achillion Pharmaceuticals competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Achillion Pharmaceuticals to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Achillion Pharmaceuticals competition on your existing holdings.

Specify up to 10 symbols:

Hype

Prediction

Low	Estimated	High
0.00	0.00	0.00

Details

Intrinsic

Valuation

Low	Real	High
0.00	0.00	0.00

Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Achillion Pharmaceuticals. Your research has to be compared to or analyzed against Achillion Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Achillion Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Achillion Pharmaceuticals.

Achillion Pharmaceuticals Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Achillion Pharmaceuticals and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Achillion and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Achillion Pharmaceuticals does not affect the price movement of the other competitor.

	HGMCF	VINS	SUM	SHAK	ZIJMF	BH	CAKE
HGMCF		-0.42	0.37	0.37	0.25	-0.04	0.35	HGMCF
VINS	-0.42		-0.81	-0.77	-0.1	-0.49	-0.78	VINS
SUM	0.37	-0.81		0.93	-0.14	0.75	0.94	SUM
SHAK	0.37	-0.77	0.93		-0.01	0.64	0.94	SHAK
ZIJMF	0.25	-0.1	-0.14	-0.01		-0.46	0.0	ZIJMF
BH	-0.04	-0.49	0.75	0.64	-0.46		0.74	BH
CAKE	0.35	-0.78	0.94	0.94	0.0	0.74		CAKE
	HGMCF	VINS	SUM	SHAK	ZIJMF	BH	CAKE

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

High positive correlations

CAKE	+ 0.94	SUM
CAKE	+ 0.94	SHAK
SHAK	+ 0.93	SUM
BH	+ 0.75	SUM
CAKE	+ 0.74	BH
BH	+ 0.64	SHAK

High negative correlations

SUM	- 0.81	VINS
CAKE	- 0.78	VINS
SHAK	- 0.77	VINS
BH	- 0.49	VINS
BH	- 0.46	ZIJMF
VINS	- 0.42	HGMCF

Risk-Adjusted Indicators

There is a big difference between Achillion Pink Sheet performing well and Achillion Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Achillion Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
HGMCF	0.83	0.00	0.00	0.13	0.00	0.00	0.57	0.00	38.00
VINS	0.19	(0.09)	0.00	0.77	0.00	0.00	0.00	0.00	6.25
SUM	1.65	0.22	0.14	0.27	1.66	(1.90)	4.18	(2.49)	9.88
SHAK	1.74	0.24	0.15	0.34	1.42	(2.23)	5.02	(2.89)	11.94
ZIJMF	2.00	(0.10)	0.00	(0.55)	0.00	0.00	5.58	(6.19)	21.80
BH	1.48	0.20	0.09	0.57	1.21	(1.93)	4.00	(2.23)	11.00
CAKE	1.76	0.24	0.14	0.34	1.63	(2.08)	4.75	(3.10)	13.08

Unable to evaluate fundamental data of [HGMCF, VINS, SUM, SHAK, ZIJMF, BH, CAKE] at this time. Please try again later

All Fundamental Data

Achillion Pharmaceuticals Competitive Analysis

The better you understand Achillion Pharmaceuticals competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Achillion Pharmaceuticals' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Achillion Pharmaceuticals' competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	HGMCF	VINS	SUM	SHAK	ZIJMF	BH	CAKE
	20.97 9.50 Harmony	0.00 0.15 Vindicator	0.29 50.94 Summit	1.04 133.73 Shake	6.63 1.83 Zijin	2.13 210.43 Biglari	1.81 50.64 Cheesecake
Market Volatility (90 Days Market Risk)	Somewhat reliable	Abnormally volatile	Very steady	Very steady	Very risky	Very steady	Very steady
Market Performance (90 Days Performance)	Very Weak	Very Weak	Solid	Solid	Very Weak	Good	Good
Odds of Financial Distress (Probability Of Bankruptcy)	About Average	Low	Very Low	Low	Below Average	Low	Low
Current Valuation (Equity Enterprise Value)	Over Valued	Over Valued	Fairly Valued	Over Valued	Over Valued	Under Valued	Over Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Not Available	Strong Buy	Buy	Not Available	Strong Sell	Buy
Trade Advice (90 Days Macroaxis Advice)	Cautious Hold	Cautious Hold	Strong Hold	Strong Buy	Strong Hold	Strong Buy	Strong Buy
Current Ratio	1.51 X	N/A	3.17 X	2.89 X	1.28 X	1.09 X	0.63 X
Net Asset	46.81 B	N/A	5.15 B	1.61 B	208.59 B	849.42 M	2.84 B
Profit Margin	(0.02) %	N/A	0.04 %	0.01 %	0.08 %	0.14 %	0.04 %
EBITDA	(340 M)	N/A	726.17 M	111.74 M	34.76 B	109.62 M	202.9 M
Operating Margin	0.1 %	N/A	0.17 %	0.04 %	0.11 %	0.05 %	0.04 %
Current Valuation	2.24 B	N/A	11.12 B	5.79 B	51.35 B	649.69 M	4.37 B
Price To Book	0.73 X	N/A	2.02 X	11.62 X	2.96 X	1.11 X	6.40 X
Retained Earnings	(4.41 B)	N/A	876.75 M	16.78 M	18.97 B	631.46 M	1.22 B
Current Asset	3.47 B	N/A	472.53 M	78.93 M	22.75 B	126.79 M	225.4 M
Five Year Return	N/A	N/A	N/A	N/A	2.57 %	N/A	2.55 %
Beta	0.82	-0.05	1.14	1.82	1.48	1.36	1.48
Number Of Employees	47	10	5.3 K	12.2 K	43.88 K	2.47 K	47.9 K
Shares Outstanding	618.03 M	N/A	175.6 M	40.03 M	5.74 B	2.07 M	51.04 M
Cash Flow From Operations	6.92 B	N/A	438.86 M	132.14 M	26.07 B	73 M	218.4 M
Annual Yield	0.01 %	N/A	N/A	N/A	0.02 %	N/A	0.02 %
Total Debt	3.18 B	N/A	2.33 B	771.33 M	49.42 B	101.24 M	1.86 B
Return On Equity	-0.033	N/A	0.0436	0.019	0.24	0.0883	0.36
Z Score	N/A	N/A	N/A	N/A	1.0	N/A	N/A
Return On Asset	0.0552	N/A	0.0464	0.0102	0.0738	0.0179	0.0388
Number Of Shares Shorted	N/A	N/A	3.19 M	3.84 M	N/A	9.23 K	5.93 M
Book Value Per Share	48.73 X	N/A	25.32 X	11.39 X	3.23 X	969.66 X	7.78 X
Current Liabilities	2.03 B	N/A	214.5 M	24 M	31.14 B	117.56 M	350.23 M
Total Asset	46.81 B	N/A	5.15 B	1.61 B	208.59 B	849.42 M	2.84 B
Debt To Equity	0.11 %	N/A	0.81 %	1.65 %	0.96 %	0.23 %	5.00 %
Short Ratio	N/A	N/A	1.64 X	3.59 X	N/A	2.97 X	4.52 X
Last Dividend Paid	0.62	N/A	N/A	N/A	0.2	N/A	1.08
Target Price	N/A	N/A	52.1	131.14	N/A	500.0	47.56
Shares Owned By Institutions	50.51 %	N/A	71.07 %	99.20 %	50.35 %	83.41 %	91.92 %
Market Capitalization	2.3 B	N/A	8.97 B	5.62 B	42.39 B	652.96 M	2.58 B
Price To Earning	4.64 X	N/A	25.03 X	112.61 X	25.53 X	0.58 X	19.59 X
Price To Earnings To Growth	N/A	N/A	1.44 X	2.55 X	N/A	(12.63) X	2.73 X
Price To Sales	0.05 X	N/A	2.39 X	4.65 X	0.15 X	1.81 X	0.73 X
Net Income	(1.05 B)	N/A	285.86 M	20.99 M	15.67 B	54.95 M	101.35 M
Earnings Per Share	0.18 X	N/A	0.85 X	0.20 X	0.12 X	35.43 X	2.64 X
Shares Owned By Insiders	12.27 %	N/A	31.91 %	5.07 %	0.34 %	0.44 %	6.85 %
Revenue	42.65 B	N/A	2.62 B	1.09 B	225.1 B	365.32 M	3.44 B
Working Capital	1.44 B	N/A	1.41 B	170.37 M	(8.39 B)	41.45 M	(359.87 M)
Cash And Equivalents	2.45 B	N/A	520.45 M	357.96 M	25.53 B	37.47 M	194.89 M
Cash Per Share	3.97 X	N/A	3.93 X	9.11 X	0.98 X	180.93 X	3.73 X
Gross Profit	9.05 B	N/A	649.35 M	313.04 M	34.69 B	152.78 M	1.28 B
Day Typical Price	9.5	0.15	51.02	133.54	1.83	211.71	50.6
Accumulation Distribution	N/A	N/A	8088.5	5246.3	N/A	50.19	7196.15
Market Facilitation Index	N/A	N/A	N/A	0.0	N/A	0.0049	0.0
Daily Balance Of Power	(9,223,372,036,855)	0.0	(0.60)	0.7041	(9,223,372,036,855)	(0.63)	1.232877
Period Momentum Indicator	(2.52)	N/A	(0.15)	1.38	(0.13)	(4.57)	0.9
Rate Of Daily Change	0.79	1.0	1.0	1.01	0.93	0.98	1.02
Day Median Price	9.5	0.15	51.07	133.44	1.83	212.36	50.58
Price Action Indicator	(1.26)	N/A	(0.20)	0.98	(0.07)	(4.21)	0.52
Relative Strength Index	89.25	N/A	75.79	79.75	39.31	72.32	60.03
Coefficient Of Variation	(5,305)	(812.40)	535.34	565.43	(5,113)	802.91	583.18
Mean Deviation	0.8343	0.1865	1.65	1.74	2.0	1.48	1.76
Jensen Alpha	(0.0001)	(0.09)	0.2201	0.2397	(0.1)	0.2027	0.2441
Total Risk Alpha	(0.65)	(0.23)	0.0353	0.0123	(0.66)	(0.10)	6.0E-4
Sortino Ratio	N/A	N/A	0.141	0.1548	N/A	0.0893	0.1373
Downside Variance	N/A	N/A	4.18	2.79	N/A	2.24	3.61
Standard Deviation	3.45	0.7693	2.28	2.24	3.47	2.18	2.32
Kurtosis	29.92	66.0	2.25	0.9629	3.47	5.69	2.0
Potential Upside	0.5742	N/A	4.18	5.02	5.58	4.0	4.75
Treynor Ratio	0.1278	0.7687	0.2712	0.336	(0.55)	0.5704	0.3436
Maximum Drawdown	38.0	6.25	9.88	11.94	21.8	11.0	13.08
Variance	11.89	0.5919	5.2	5.03	12.04	4.74	5.4
Market Risk Adjusted Performance	0.1378	0.7787	0.2812	0.346	(0.54)	0.5804	0.3536
Risk Adjusted Performance	(0.01)	(0.09)	0.1494	0.1418	(0.01)	0.1017	0.1378
Skewness	(1.61)	(8.12)	0.4242	0.7192	0.3393	1.75	0.7527
Semi Deviation	N/A	N/A	1.66	1.42	N/A	1.21	1.63
Information Ratio	(0.06)	(0.30)	0.1264	0.1155	(0.06)	0.0613	0.1122
Value At Risk	N/A	N/A	(2.49)	(2.89)	(6.19)	(2.23)	(3.10)
Expected Short fall	N/A	N/A	(1.90)	(2.23)	N/A	(1.93)	(2.08)
Downside Deviation	N/A	N/A	2.04	1.67	N/A	1.5	1.9
Semi Variance	N/A	N/A	2.76	2.03	N/A	1.47	2.67

Achillion Pharmaceuticals Competition Performance Charts

Five steps to successful analysis of Achillion Pharmaceuticals Competition

Achillion Pharmaceuticals' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Achillion Pharmaceuticals in relation to its competition. Achillion Pharmaceuticals' competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of Achillion Pharmaceuticals in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Achillion Pharmaceuticals' competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Achillion Pharmaceuticals, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Achillion Pharmaceuticals position

In addition to having Achillion Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Printing and Publishing Thematic Idea Now

Printing and Publishing

Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Printing and Publishing theme has 21 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Printing and Publishing Theme or any other thematic opportunities.

View All Next

Launch

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Achillion Pink Sheet

If you are still planning to invest in Achillion Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Achillion Pharmaceuticals' history and understand the potential risks before investing.

	Money Managers Screen money managers from public funds and ETFs managed around the world
	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC